[Improved gastric tolerance of antirheumstic agents by means of concomitant gastrozepin therapy].
A double blind trial is described in which the effect of the specific gastric secretion inhibitor, Gastrozepin, was tested on gastric disturbances during treatment with the antirheumatic drug indometacin. It was shown on further treatment with indometacin and concomitant Gastrozepin therapy that the symptoms could be improved or completely relieved.
D000328:Adult; D000368:Aged; D001570:Benzodiazepinones / Q000627:therapeutic use*; D004336:Drug Antagonism; D004341:Drug Evaluation; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D012216:Rheumatic Diseases / Q000188:drug therapy*
D001570:Benzodiazepinones; D007213:Indomethacin
Verbesserte Magenverträglichkeit von Antirheumatika bei gleichzeitiger Gabe von Gastrozepin.